The Nasdaq composite was down 1.84% while the RSP was up 2.11% That pretty much said it all. There was rotation all right and painful if you weren’t on the right side of it. Most of these insiders were. The average return last week of the stocks we highlight was 7.89%. I think you’d be happy with that in your portfolio.
Name: William C. Boor
Position: President & CEO
Transaction Date: 02-04-2026 Shares Bought: 1,000 shares an Average Price Paid of $495.00 for Cost: $495,000
Name: David A. Greenblatt
Position: Director
Transaction Date: 02-03-2026 Shares Bought: 500 shares an Average Price Paid of $469.45 for Cost: $234,725
Company: Cavco Industries Inc. (CVCO)
Cavco Industries, Inc. designs, manufactures, and sells factory-built homes in the United States, such as modular homes, park model RVs, vacation cabins, and commercial structures. The company also offers home financing and insurance, and its products are distributed via merchants, developers, and communities. It was created in 1965 and is based in Phoenix, Arizona.
William C. Boor is the President and CEO of Cavco Industries Inc., a post he has held since April 15, 2019, and a member of the Board of Directors since 2008. Before joining Cavco as CEO, he was the CEO of Great Lakes Brewing Company and held key executive positions at Cliffs Natural Resources, including Executive Vice President for Corporate Development, Chief Strategy and Risk Officer, and President of Ferroalloys. Earlier in his career, he had senior positions at Eagle Materials, Centex, Weyerhaeuser, and Procter & Gamble, obtaining experience in manufacturing, strategy, finance, and operations. He earned his MBA, General Management degree, from the Harvard Business School and BS, Chemical Engineering degree, from Penn State University.
David A. Greenblatt has been a director for Cavco Industries Inc. since October 2008. He retired as Senior Vice President and Deputy General Counsel of Eagle Materials, Inc., where he worked from 2005 to 2012. He previously held senior legal and executive positions at Centex Corporation, including Vice President and General Counsel of its Investment Real Estate Group and General Counsel of Cavco. He formerly worked as a corporate and securities attorney with Hughes & Luce. He is also the President of White Sand Investments, LLC, a real estate investment and management firm, and provides considerable legal, governance, and industry knowledge to the Cavco Board from his lengthy involvement with the company and the construction sector. He earned his JD degree from The University of Texas School of Law and a BS in Economics degree from the University of Pennsylvania.
Insomniac Hedge Fund Guy Opinion: Cavco is a well-run industrial compounder with real operational heft in a niche housing market, and its integrated financing/insurance adds defensibility. Growth isn’t explosive but is steady with margin resilience, and recent insider buying from the CEO signals confidence at the top. That said, recurring revenue is tiny, the moat is moderate, not unbreachable, and the broader housing cycle remains a big swing factor. Valuation sits near or slightly above reasonable DCF fair value, pricing in a near-perfect macro and execution backdrop — not your usual deep margin of safety. For true value hunters, the premium built into shares against cyclic risk undermines an unqualified bullish stance, though selective allocators with a long horizon might appreciate the quality. This is not financial advice — just one market veteran’s take.
Name: Thomas Patrick Jr. Joyce
Position: Director
Transaction Date: 02-06-2026 Shares Bought: 1,400 shares an average price paid of $358.46 for Cost: $501,844
Company: Roper Technologies Inc. (ROP)
Roper Technologies, Inc. creates vertical software and technology-enabled products in the United States, Canada, Europe, Asia, and elsewhere. The Application Software division provides comprehensive management, diagnostic and laboratory information management, enterprise software and information solutions, campus technology and payment, cloud-based financial analytics and performance management software, cloud-based software for the property and casualty insurance industry, and foodservice technologies. The company’s network tools business offers cloud-based data, collaboration, and estimating automation tools; an electronic marketplace; visual effects and 3D content software; pharmacy software solutions; and so on. The company was established in 1981 and is headquartered in Sarasota, Florida.
Thomas Patrick Jr. Joyce has served as a Director of Roper Technologies, Inc., since October 22, 2021, when he was elected to the company’s Board of Directors and began serving as an independent board member, including on key committees such as Audit and Compensation. Before joining Roper, Joyce had a long executive career at Danaher Corporation, which he joined in 1989 and where he served in leadership roles, culminating as President and CEO from 2014 to 2020, retiring from the company in 2021. At Roper, he provides strategic oversight, drawing on his extensive experience in global business, finance, and operations. Joyce earned a Bachelor of Science in Economics from the College of the Holy Cross.
Insomniac Hedge Fund Guy Opinion: ROP’s business is a cash-generating, niche technology compounder with a diversified, high-recurring revenue base and a moat forged through disciplined acquisitions rather than product monopoly. Its maneuverability through acquisition cycles and strong free cash flow underpin a valuation gap versus intrinsic DCF value. Yet, the reliance on bought growth and decelerating organic trends means you’re paying for execution as much as the story. Recent insider buying suggests management sees the pullbacks as opportunities; short interest remains low — a sign that broad institutional sentiment is cautious but not bearish. At current valuations, you’re not overpaying relative to intrinsic cash power, but you *aren’t getting a discount *either. Roper is quality, not a bargain — a compounder that earns its wings through disciplined execution, not hype. Not financial advice — just one sharp market mind’s take.
Name: Andy L. Nemeth
Position: Director
Transaction Date: 02-04-2026 Shares Bought: 2,000 shares an average price paid of $245.00 for Cost: $490,000
Company: Standex International Corp (SXI)
Standex International Corporation manufactures and distributes goods and services to commercial and industrial customers in the United States and around the world. It operates in five segments: electronics, engineering technologies, scientific, engraving, and specialty solutions. The company provides reed relays, fluid level, proximity, motion, flow, HVAC condensate, custom electronic and current sensors, instrument transformers, wound transformers, bushings, inductors, current sense and planar transformer technology, value added assemblies, and mechanical packaging applications under the brands Standex Electronics, Standex-Meder Electronics, Renco Electronics, Northlake Engineering, Agile Magnetics, Sensor Solutions, Standex Electronics Japan, Minntronix, Na The company was founded in 1955 and is based in Salem, New Hampshire.
Andy L. Nemeth is an American business executive who has served as a Director of Standex International Corp., since May 2, 2025, when he was appointed by the Board as a Class III director to fill a vacancy on the company’s Board of Directors. Before joining Standex’s board, Nemeth had a long career at Patrick Industries, Inc., which he joined in 1996 and where he has held numerous senior leadership roles; he has been Chairman since 2024 and Chief Executive Officer since January 2020, helping guide strategic growth and operational performance in industrial markets. He holds a Bachelor of Business Administration degree in Accounting from the University of Wisconsin-Eau Claire.
Insomniac Hedge Fund Guy Opinion: Standex is industrial DNA with a manufacturing twist: diversified but not immune to cyclicality and leverage. Its profit trajectory and backlog growth are compelling, and recent insider buying suggests management sees long-term value here. But organic growth is uneven, and there’s no sticky recurring revenue engine — it’s still largely project/industrial sales. The modest short interest and improving margins align with operational health, but the valuation isn’t screaming cheap; you’re paying a multiple that assumes continued acquisition execution and margin resilience. Standex is a quality industrial compounder — not a tech moat stock — with value tied to execution on grid and defense growth and disciplined debt reduction. Its DCF implies fair value close to today’s levels under conservative assumptions, so the margin of safety is slim unless organic trends accelerate.
Name: Jennifer Pollino
Position: Director
Transaction Date: 01-29-2026 Shares Bought: 1,500 shares an average price paid of $184.29 for a cost of $276,435
Name: Max H. Mitchell
Position: Chairman, President, and CEO
Transaction Date: 01-30-2026 Shares Bought: 1,000 shares an average price paid of $183.71 for a cost of $183,710
Name: Sanjay Kapoor
Position: Director
Transaction Date: 01-29-2026 Shares Bought: 2,814 shares an average price paid of $177.68 for a cost of $499,992
Company: Crane Co (CR)
Crane Company and its subsidiaries manufacture and market designed industrial goods in the United States, Canada, the United Kingdom, Continental Europe, and worldwide. The company is divided into two business segments: aerospace and electronics, and process flow technologies. The Aircraft & Electronics section provides important components and systems, such as original equipment and aftermarket parts, to the commercial aircraft, military aerospace, defense, and space industries. This category also provides pressure sensors for aviation engine control, aircraft brake systems for commercial and military aircraft, power conversion solutions for defense and space applications, and lubrication systems. Crane Co. was formerly known as Crane Holdings, Co. Crane Company was founded in 1855 and is based in Stamford, Connecticut.
Jennifer M. Pollino has been a Crane Company director since 2023, when the company separated and became an independent public organization. In her job, she oversees governance and brings vast experience in corporate leadership, financial management, and organizational efficiency. She has extensive experience in auditing, remuneration, and human capital matters, which she uses to support board-level decision-making and long-term strategy planning. Her experience enables her to lead management with a disciplined and people-oriented approach. Pollino is a certified public accountant. She completed her BBA in Accounting from the University of Notre Dame and a Master of Science in Executive Coaching from Queens University in Charlotte.
Max Mitchell serves as Crane Company’s Chairman of the Board, President, and CEO. He was appointed president and CEO in 2014, and he will also serve as chairman in April 2024. During his stint as CEO, Mr. Mitchell oversaw a broad overhaul of Crane’s portfolio. He expanded internal investments, focusing on next-generation technologies and new product development in the company’s fastest-growing areas. He has worked with the organization since 2004. He completed his MBA in Finance from the University of Pittsburgh’s Katz Graduate School of Business and a BA from Tulane University.
Sanjay Kapoor has served as an independent director on Crane Company’s board since April 2023. At Crane, he sits on important governance committees such as the Audit Committee and the Management Organization & Compensation Committee, where he uses his significant financial and operational oversight experience to improve corporate governance and risk management. Kapoor, who has been designated by the Board as an audit committee financial specialist, provides decades of experience as a top executive in the global aerospace and manufacturing industries, which will improve Crane’s strategic oversight. He completed his Bachelor of Commerce from Delhi University and an MBA from the Cranfield School of Management.
Insomniac Hedge Fund Guy Opinion: Crane’s industrial franchise is no glamour tech story — it’s gritty engineering execution backed by durable relationships that yield above-market margin expansion. It’s not recurring revenue in the SaaS sense, but its aftermarket and defense service attach rates provide quasi-recurring profitability. Recent acquisitions and backlog growth underpin mid-single-digit organic sales growth with leverage into EPS that’s growing north of 20% year-over-year. Insider buying by the sitting CEO reinforces confidence after multiple beats and raises, while short interest remains muted. The leadership transition signifies continuity, not disruption. Profitability compares favorably in industrial leanings, but the valuation still trades at a premium to cyclic peers. A conservative DCF with an 8% discount suggests intrinsic value around current levels — not a screaming discount, but reasonable if macro holds and execution stays tight. Strengths in aerospace and emerging niches like nuclear sensors are offset by exposure to cyclical end markets and integration risks. Customer concentration isn’t extreme per filings, but large OEM spending swings can impact quarterly flows. Bottom line: CR is a fundamentally solid industrial compounder with a credible moat in engineered solutions — but the valuation embeds strong growth assumptions, and the margin of safety is thin without further operational upside or secular tailwinds. Not financial advice — this is one market-savvy take.
Name: Mark Vergnano
Position: Director
Transaction Date: 02-05-2026 Shares Bought: 7,665 shares an average price paid of $131.94 for Cost: $1,011,320
Company: Johnson Controls International plc (JCI)
Johnson Controls International plc, along with its subsidiaries, designs, manufactures, commissions, and retrofits building goods and systems in the United States, Europe, Asia Pacific, and beyond. It operates in four segments: Building Solutions North America, Building Solutions EMEA/LA, Building Solutions Asia Pacific, and Global Products. The company manufactures, sells, installs, and services heating, ventilation, air conditioning, controls, building management, refrigeration, integrated electronic security, integrated fire detection and suppression systems, and fire protection and security products. Customers for its goods and services include commercial, institutional, industrial, data center, and government entities. Johnson Controls International plc was established in 1885 and is headquartered in Cork, Ireland.
Mark Vergnano is a seasoned business leader who has served as a Director of Johnson Controls International plc since September 2016. Vergnano joined Johnson Controls itself in 2015 as part of the leadership transition around that merger and has since provided governance and strategic oversight at the board level. Before his board role at JCI, he held extensive executive leadership positions, including president and CEO of The Chemours Company and long service at DuPont, bringing deep industrial and global business experience to Johnson Controls. He earned a Bachelor of Science in Chemical Engineering from the University of Connecticut and an MBA from Virginia Commonwealth University.
Insomniac Hedge Fund Guy Opinion: JCI is a transitional industrial titan — engineering tomorrow’s smart buildings while still managing today’s hardware business. The push into recurring services and digital control platforms goes a long way toward de-cyclicality, but the moat isn’t yet as deep as pure software franchises. Recent insider buying at elevated levels suggests management believes in execution and margin expansion under the new CEO. Still, the stock’s valuation reflects those expectations — not cheap, just reasonable compared to cyclical peers. With short interest minimal and a large backlog backing future sales, the risk of a mean reversion rally exists. But don’t expect rapid rerating until JCI proves recurring revenue and retention trends dominate the P&L. Not financial advice — this is one smart veteran’s take, not a guaranteed roadmap.
Name: James A. Faulconbridge
Position: Director
Transaction Date: 02-04-2026 Shares Bought: 3,000 shares an average price paid of $129.62 for Cost: $388,860
Company: Hawkins Inc. (HWKN)
Hawkins, Inc. is a water treatment and specialty ingredients company in the United States. The company operates in three segments. The water treatment business offers chemicals, products, equipment, services, and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agricultural water. The Industrial division provides industrial chemicals, goods, and services to the agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. The health and nutrition businesses provide ingredient distribution, processing, and formulation solutions to makers of nutraceuticals, functional foods and beverages, personal care, dietary supplements, and other nutritious foods, as well as health and wellness products. Hawkins, Inc. was formed in 1938 and is based in Roseville, Minnesota.
James A. Faulconbridge has been a director of Hawkins, Inc., since 2006, when he was first elected to the company’s Board of Directors, bringing long-standing governance experience to the specialty chemicals distributor. He also serves as president of Karges-Faulconbridge, Inc., an engineering and technical services firm he has led since the same year, which provides him with technical and industry insight relevant to Hawkins’ business. Faulconbridge joined Hawkins’ board in 2006 and has since participated in key board committees, including Governance & Nominating and Audit. He graduated from North Dakota State University, where he completed his higher education before his professional career.
Insomniac Hedge Fund Guy Opinion: HWKN is a steady, acquisition-driven specialist in water treatment and industrial chemicals with a respectable track record and shareholder return discipline. It’s not a high-flyer tech growth story — but it does have defensible operational positioning in essential markets. That said, valuation feels rich relative to earnings and risk; pricing appears to assume flawless integration of acquisitions and continued margin expansion that isn’t guaranteed in chemicals. The lack of SaaS-like recurring revenue metrics and no clear net retention data means you’re paying a premium for industrial cash flow, not sticky digital economics. With short interest moderate and limited clear insider buys, sentiment seems cautious. The company is reliable, but at ~$130+ there isn’t much margin of safety for the value-minded. This isn’t financial advice — just a sharp take from someone who’s seen cyclical names get punished when growth slows and multiples compress.
Name: Robert Livingston
Position: Director
Transaction Date: 02-05-2026 Shares Bought: 10,000 shares an Average Price Paid of $128.51 for Cost: $1,285,080
Company: Amphenol Corp. (APH)
Amphenol Corporation develops, manufactures, and markets electrical, electronic, and fiber-optic connectivity solutions worldwide. Connectors, cable assemblies, antennas, sensors, printed circuit boards, and power distribution systems are utilized in a variety of industries, including automotive, aerospace, industrial, IT, mobile networks, and communications. Founded in 1932, the company serves OEMs and service providers through direct sales and a network of distributors. Its headquarters are in Wallingford, Connecticut.
Robert A. Livingston has been a Director of Amphenol Corp. since December 2018. He has substantial leadership expertise in the industrial and manufacturing sectors, most notably as the President and CEO of Dover Corporation, where he oversaw global operations and strategic growth projects. Throughout his career, he has held senior executive positions in Dover’s many business areas and served on multiple corporate boards, bringing extensive experience in finance, operations, and corporate governance. Livingston earned a Bachelor of Science in Business Administration from Salisbury University.
Insomniac Hedge Fund Guy Opinion: Amphenol is a classic industrial capitalist juggernaut riding the AI-data-center and connectivity megatrend with enviable execution — diversified revenue streams, best-in-class margins, and a roll-up strategy that rarely cramps earnings via goodwill impairments. Its non-software “recurring” revenue characteristics from OEM contracts give it enterprise-like stability without the finicky churn metrics. Valuation discipline matters: at today’s multiples, the stock prices a lot of perfection — a DCF suggests headwinds if growth slows. Recent insider selling is more financial planning than signaling, and minimal short interest underscores broad confidence. APH’s moat is real, but the premium valuation means patient entry points beat chasing peaks. A strategic growth play, not a value bargain. Not financial advice — razor-edged market view.
Name: Daniel J. Starks
Position: Director
Transaction Date: 02-04-2026 Shares Bought: 10,000 shares an average price paid of $108.73 for Cost: $1,087,331
Company: Abbott Laboratories (ABT)
Abbott Laboratories and its subsidiaries discover, develop, manufacture, and sell health-care products around the world. It operates in four business segments: established pharmaceutical products, diagnostic products, nutritional products, and medical devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière’s disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as anti-infective clarithromycin, influenza vaccine, and products. In addition, the company offers nutritious items for children and adults, as well as infant formula. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
Daniel J. Starks has served as an Independent Director of Abbott Laboratories since 2017, when he was elected to the company’s board following Abbott’s acquisition of St. Jude Medical. Prior to joining Abbott’s board, Starks spent his career in the medical device industry, notably joining St. Jude Medical in 1996 and rising through leadership roles there, including Chairman, President, and Chief Executive Officer, until his retirement in 2016. At Abbott, he contributes governance experience and industry insight as a member of key board committees. He holds a J.D. from the University of Minnesota.
Insomniac Hedge Fund Guy Opinion: Abbott is a durable healthcare compounder with real moats in consumable devices and regulated assets, now pivoting into high-growth diagnostics with a bold acquisition. That said, its valuation does not leave tons of margin for error — execution must be tight. Insider buys signal confidence, and low short interest deprives us of a contrarian setup, but fundamentals are robust. This isn’t a speculative moonshot — it’s a defensive gem with measured upside if oncology diagnostics and device growth hit their marks. Not personalized advice — just where the risk/reward currently tilts in my view.
Name: Badrinarayanan Kothandaraman
Position: President And CEO
Transaction Date: 02-05-2026 Shares Bought: 5,000 shares an Average Price Paid of $51.98 for Cost: $259,884
Company: Enphase Energy Inc. (ENPH)
Enphase Energy, Inc. creates and markets residential energy solutions for the solar sector, including microinverters, battery storage systems, energy management software, EV charging solutions, and monitoring services. Its technology provides energy conversion, monitoring, and control at the solar panel level for residential clients all over the world. The company was established in 2006 and is based in Fremont, California.
Badrinarayanan Kothandaraman is the President and CEO of Enphase Energy Inc., a position he has held since September 2017. He also serves on the company’s Board of Directors. He joined Enphase in April 2016 as Chief Operating Officer, having previously held key executive positions at Cypress Semiconductor. He has received his BTech degree from IIT Madras and his M.S. degree in materials science from U.C. Berkeley. He also received his degree in Executive MBA, Business Administration and Management, General, from the Stanford University Graduate School of Business.
Insomniac Hedge Fund Guy Opinion: Enphase built a smart hardware stack and has squeezed strong margins in an unforgiving solar market, but it’s not a pure recurring revenue engine like a SaaS business. Revenue growth has swung from blistering to contracting as policy, tariffs, and demand cycles bite. Insider selling and elevated short interest underscore skepticism. A disciplined DCF suggests upside from current levels, but that’s contingent on demand stabilization—not blind attach to green energy narratives. ENPH is a cyclical hardware play with optional software promise, not a dependable recurring revenue growth stock. At current prices, the risk/reward isn’t generous unless you’re prepared to ride through volatile solar cycles and policy swings. This is not financial advice—do your own due diligence.
Name: Jan Eli B. Craps
Position: Executive Chair
Transaction Date: 02-06-2026 Shares Bought: 50,000 shares an average price paid of $48.65 for Cost: $2,432,330
Company: Lamb Weston Holdings Inc. (LW)
Lamb Weston Holdings, Inc. produces, distributes, and markets frozen potato products in the United States, Canada, Mexico, and abroad. It sells frozen potatoes, commercial ingredients, and appetizers under the Lamb Weston brand, as well as under several customer brands. It sells its products to quick service and full-service restaurants and chains, wholesale, grocery, mass merchants, club retailers, and specialty retailers, as well as foodservice distributors and institutions such as businesses, educational institutions, independent restaurants, regional chain restaurants, and convenience stores, via a network of internal sales personnel and independent brokers, agents, and distributors. Lamb Weston Holdings, Inc. was established in 1950 and is based in Eagle, Idaho.
Jan Eli B. Craps was appointed Executive Chair of Lamb Weston Holdings, Inc., effective February 6, 2026, when the company’s Board of Directors created the role to leverage his extensive global leadership experience and strategic oversight capabilities. He joined Lamb Weston in 2026 with this executive leadership position, bringing deep industry experience from his previous roles, including CEO and Co-Chair of Budweiser Brewing Company APAC at Anheuser-Busch InBev, where he served until April 2025 and held leadership roles dating back to 2002. Craps’ appointment underscores Lamb Weston’s focus on board leadership, governance, and international market execution. He earned his master’s degree in business engineering from KU Leuven and completed executive education courses at Wharton-INSEAD.
Insomniac Hedge Fund Guy Opinion: LW is a functional food-production play with entrenched customer ties and cash flows — but it’s not the “moat + recurring revenue” story that commands premium multiples. The stock is cheap for a reason: margin headwinds, competitive pricing, and cyclic restaurant demand. Insider buying is a positive contrarian signal, but short interest and pressure on margins warn against complacency. Only if execution of cost cuts and volume gains outpace consensus can this value deepened. It’s a value-leaning cyclical in a sector where pricing power is thinner than typical consumer staples champions — worth watching, not blindly buying. Not financial advice.
Name: Christopher M. Connor
Position: Director
Transaction Date: 01-30-2026 Shares Bought: 25,000 shares an average price paid of $40.37 for a cost of $1,009,250
Company: International Paper Co (IP)
International Paper Company manufactures and sells renewable fiber-based packaging and pulp products throughout North America, Latin America, Europe, and North Africa. It operates in two segments: industrial packaging and global cellulose fibers. The company sells linerboard, medium, whitetop, recycled linerboard, recycled medium, and saturating kraft, as well as pulp for a variety of applications, including diapers, towel and tissue products, feminine care, incontinence, and other personal care products, as well as specialty pulps for use in textiles, construction materials, paints, coatings, and other industries. The company offers its products directly to consumers and converters, as well as through agents, resellers, and distributors. The company was founded in 1898 and is based in Memphis, Tennessee.
Christopher M. Connor has served as International Paper Company’s lead independent director since October 1, 2017, when he was elected to the board and assigned committee assignments. Before joining the board of International Paper, Connor worked as an executive at The Sherwin-Williams Company, where he rose to the position of chairman and CEO. He eventually rose to the position of Lead Director of International Paper, where he provided governance and strategic control. He completed his BA from The Ohio State University, where he studied sociology.
Insomniac Hedge Fund Guy Opinion: International Paper is a structural giant caught in cyclical purgatory. Its core packaging franchise is real, but scale alone doesn’t insulate it from weak global demand, high capex, and integration drags — all evidenced by recent losses and high short interest. The strategic shift toward focused regional entities and operational rigor under Silvernail is the right play, but execution risk is real and currently reflected in depressed margins and a lack of a true recurring revenue base. Institutional insiders holding big stakes signal long-term belief, but public insider buying is shallow. On a DCF basis, with conservative cash flow assumptions and realistic growth, the stock trades with slim margin of safety — not compelling for deep value hunters but worthy of a tactical position for contrarian cyclical exposure. Not financial advice — this is my market-seasoned take.
Name: Douglas R. Deason
Position: Director
Transaction Date: 02-04-2026 Shares Bought: 25,000 shares an average price paid of $20.80 for Cost: $519,950
Company: Galaxy Digital Inc. (GLXY)
Galaxy Digital Inc. operates in the digital asset and data center infrastructure markets. The company’s digital assets platform provides institutional users with trading, advisory, asset management, staking, self-custody, and tokenization capabilities. In addition, the firm invests in and operates data center infrastructure to enable AI and high-performance computing, addressing the growing demand for scalable energy and compute solutions in the United States. The company was founded in 2018 and is based in New York, with offices around North America, Europe, the Middle East, and Asia.
Douglas R. Deason is an American business executive who was appointed as a Director of Galaxy Digital Inc. on July 28, 2025, joining the company’s Board of Directors as an independent director and becoming a member of its Nominating and Corporate Governance Committee. Prior to this board role, Deason had an extensive career in investment and corporate leadership, including serving as president of Deason Capital Services, LLC since 2011 and earlier executive roles in other firms, giving him broad experience in finance and business strategy. He holds a Bachelor of Science degree in data processing and quantitative analysis (computer science) from the University of Arkansas.
Insomniac Hedge Fund Guy Opinion: Galaxy Digital is a high-variance hybrid — part crypto financier, part AI infrastructure builder — that offers a fascinating asymmetric risk/reward if you really believe in digital assets and AI compute demand. Its revenue looks huge on paper because it books full trade volumes as “revenue,” which distorts traditional comparables and masks the underlying fee/recurring base. The competitive moat is thin, meaning execution and market cycles drive performance, not durable franchise value. Management’s pivot into data centers and institutional services is strategic, but the balance between crypto profit volatility and infrastructure growth execution is a tightrope act. Recent insider buying by a director hints at confidence, but past executive selling and Q4 losses warn against blind optimism. Short interest sits in an uncomfortable middle ground — enough skepticism to matter, not enough to ignite a squeeze. The DCF indications are tantalizingly high, yet they rest on bullish crypto pricing and a seamless Helios ramp. Galaxy is not a steady cash-flow machine; it’s a catalyst-driven play that requires risk tolerance for crypto cyclicality and big infrastructure capex. For experienced traders, it’s a story worth watching with position sizing discipline — not a plain-vanilla value stock. This is not financial advice — just one market-savvy bot’s take.
Name: Peter D. Fitzsimmons
Position: President & CEO
Transaction Date: 02-03-2026 Shares Bought: 13,350 shares an average price paid of $18.80 for Cost: $251,017
Company: Monro Inc. (MNRO)
Monro, Inc. operates retail tire and vehicle service stores in the United States. It specializes in tire replacement and related services, automotive undercar repair, and routine maintenance for passenger automobiles, light trucks, and vans. Other products and services offered by the company include brakes, mufflers, and exhaust systems, as well as steering, drive train, suspension, and wheel alignment. It runs locations under the following brand names: Monro Auto Service and Tire Centers, Tire Choice Auto Service Centers, Mr. Tire Auto Service Centers, Car-X Tire & Auto, Tire Warehouse Tires for Less, Ken Towery’s Tire & Auto Care, Mountain View Tire & Auto Service, and Tire Barn Warehouse. The company was founded in 1957 and is based in Fairport, New York.
Peter Fitzsimmons has been President and Chief Executive Officer of Monro Inc. since March 2025, and he signed a formal employment agreement directly with the company in December 2025. He has over 30 years of senior management and advising expertise, having worked for a variety of retail and car repair organizations. He was previously a partner and managing director at AlixPartners, a global consulting firm, where he held client-focused leadership roles, advising companies and acting as an advisor, CEO, and CFO for clients undergoing significant transformation, turnaround, and operational improvement efforts. He graduated from Harvard College with a Bachelor of Arts and received his MBA from Dartmouth College’s Tuck School of Business.
Insomniac Hedge Fund Guy Opinion: Monro’s strategy isn’t bad — trimming weak stores, leaning into digital funnels, and insiders buying is noteworthy. But this isn’t a moat-rich growth engine; it’s a legacy service play facing secular pressures (labor, EVs) and margin squeeze with modest growth. The valuation today still prices a flawless turnaround that’s far from proven. Not enough margin of safety for a deep value wager — this is a restructuring story with narrow optionality, not a structural compounder.
Name: Leon O Jr. Moulder
Position: Chief Executive Officer
Transaction Date: 02-02-2026 Shares Bought: 57,000 shares an average price paid of $17.96 for a cost of $1,023,720
Company: Zenas BioPharma Inc. (ZBIO)
Zenas BioPharma, Inc., a clinical-stage biopharmaceutical firm, develops and commercializes breakthrough immunology-based treatments. Obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb, is the company’s flagship product candidate. It is used to treat immunoglobulin G4-related illness, multiple sclerosis, and systemic lupus erythematosus, among other indications. The business also produces ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; and ZB001, an anti-IGF-1R monoclonal antibody. Zenas BioPharma (Cayman) Limited was the company’s previous name until August 2023, when it changed to Zenas BioPharma, Inc. The company was established in 2019 and is based in Waltham, Massachusetts.
Leon O Jr. Moulder has been a Chief Executive Officer at Zenas BioPharma, Inc., since August 2023, and Chairman and member of the board of directors since 2020. Mr. Moulder began his career as a clinical pharmacist and went on to work with Sanofi S.A. precursor firms, commencing with Marion Laboratories Inc. for 17 years. Mr. Moulder is a Temple University trustee and the chair of Temple University Japan. He serves on the councils of the University of Chicago Booth School of Business and the Polsky Center for Entrepreneurship and Innovation. Mr. Moulder earned a pharmacy degree from Temple University and an MBA from the University of Chicago Booth School of Business.
Insomniac Hedge Fund Guy Opinion: Zenas BioPharma is pure late-stage biotech optionality — a clinical catalyst story wrapped in high financial burn and zero recurring revenue. Its value rests almost entirely on upcoming Phase 3 readouts and partner achievements. Insider buying suggests management sees meaningful upside ahead, but that’s conviction, not confirmation. With no commercial revenues and a massive cash burn, ZBIO’s valuation is betting on perfect execution and clinical success. The current valuation incorporates significant optimism relative to a risk-adjusted DCF framework, leaving limited margin of safety for traditional investors. It’s a high-volatility, high-binary-event play best suited to catalyst-driven traders, not value seekers — success or failure will pivot on clinical readouts, not quarterly topline. Not financial advice, just one sharp, experienced market take.
Name: Raul J. Fernandez
Position: President And CEO
Transaction Date: 02-02-2026 Shares Bought: 16,446 shares an Average Price Paid of $15.24 for Cost: $250,706
Company: DXC Technology Co. (DXC)
DXC Technology Company offers IT services and digital transformation solutions to businesses and the public sector throughout the world through its Global Business Services and Global Infrastructure Services segments. The company provides consulting, software engineering, analytics, application services, cloud infrastructure, cybersecurity, and IT outsourcing solutions to assist businesses in modernizing operations and managing mission-critical systems. DXC Technology, founded in 1959, is headquartered in Ashburn, Virginia.
Raul J. Fernandez has been a President and CEO at DXC Technology Co. since February 2024. He joined the company’s board in 2020 and later became President and CEO, bringing more than three decades of leadership expertise in the technology and digital services business. Before joining DXC as an executive, he started and ran several technology firms, including Proxicom and ObjectVideo, and has served on other public company boards, including Broadcom. He is also the Vice Chairman and co-owner of Monumental Sports and Entertainment. He earned his Bachelor of Arts in Economics degree from the University of Maryland.
Insomniac Hedge Fund Guy Opinion: DXC is a value-trap candidate if growth doesn’t reaccelerate. The stock’s cheap for a reason — legacy drag and execution risk persist. Possible turnarounds require visible traction in recurring cloud and AI services plus margin expansion (no small feat). If execution stabilizes, free cash flow could support buybacks and value unlock. Right now, the valuation gives only modest cushion; this is deep value with real risk, not a safe compounder. Have a margin of safety and expect volatility. — Not financial advice.
Name: Kathleen E. Johnson
Position: President & CEO
Transaction Date: 02-05-2026 Shares Bought: 78,685 shares an average price paid of $6.35 for Cost: $499,925
Company: Lumen Technologies Inc. (LUMN)
Lumen Technologies, Inc., a networking firm, offers integrated solutions and services to both commercial and consumer customers in the United States and abroad. The company operates in two segments: business and mass markets. It provides dark fiber and conduit, edge cloud, internet protocol, voice over IP, managed security, software-defined wide area networks, unified communications and collaboration, and optical services; ethernet and VPN data network services; and legacy services to manage cash flow, including time division multiplexing voice and private line; other legacy services, such as Synchronous Optical Network-based ethernet, legacy data hosting services, and conferencing services. Lumen Technologies, Inc., was established in 1968 and is based in Monroe, Louisiana.
Kathleen E. Johnson is the President & Chief Executive Officer of Lumen Technologies Inc. and has served in that role since November 7, 2022, when she was appointed by the company’s Board of Directors as part of a leadership transition. She joined Lumen in 2022, stepping into the top executive position as Jeff Storey retired, and also serves as a member of Lumen’s board. Before Lumen, Johnson held senior leadership roles at major technology companies, including Microsoft, GE Digital, Oracle, and others, bringing deep experience in business and digital transformation to her current role. She earned a bachelor’s degree in electrical engineering from Lehigh University and an MBA from the Wharton School at the University of Pennsylvania.
Insomniac Hedge Fund Guy Opinion: Lumen has a credible transformation narrative — pivoting from a legacy telecom to a digital network services provider anchored in AI-driven enterprise connectivity. But the execution bar is high: revenue remains pressured by legacy declines, profitability trails telco peers, and debt remains heavy. The narrow moat of fiber infrastructure is a real asset, though competitors like AT&T/Verizon blunt pricing power. Recurring revenue is growing via multiyear PCF/NaaS contracts, yet net retention metrics aren’t transparent — a data hole for true SaaS-style evaluation. Insider buying from the CEO signals internal confidence; short interest at ~6–7% underscores persistent skepticism. A conservative DCF suggests valuation doesn’t yet offer a generous margin of safety, given execution risk and capital intensity of network buildouts. Strategic wins (AI contracts, consumer fiber divestiture) sharpen focus on higher-value segments, but competition and execution risk remain front-and-center. At current levels, LUMN is a turnaround story with conditional upside, better suited to growth-oriented risk appetite than value-centric investors.